DOWNLOAD

URS for small flexible filler technology

26 June 2018
Fill Finish
URS for small flexible filler technology
148.97 KB
287 downloads

The biopharmaceutical industry is transitioning from an era of blockbuster drugs that treat large segments of the population with a common ailment, to one of more personalized/specialized medicines for much smaller patient populations. Consequently, manufacturing operations are evolving from large batches and high-speed filling lines aimed at driving down unit costs, to agile lines that can rapidly switch between various lower volume products line to maximize utilization.

One of the more promising recent advancements in pharmaceutical manufacturing is the development of single-use systems. These systems require far less capital to build and great promise for easy technology transfer, enabling companies to manufacture at sites around the world at a lower cost. However, the success of this approach has been limited by a lack of available single-use technologies such as sensors and mixers.

To meet increasing sterility requirements, the industry has embarked in an ongoing quest to move the operator further away from the filling process, literally. Historically, operators used to hover above the filling operation, wearing minimal gowning or personal protective equipment. Through the years, however, filling operations have become much more sensitive to environmental conditions, leading to the introduction of stringent gowning requirements and placing operators behind isolators in sophisticated garments. Before long, most filling will be performed robotically, removing operators even further from the proximity of the filling operation. Eventually, operators will likely control filling from a central control room that may not be located in the same state as operations, let alone the same building.

Modularity will also play a major role in filling operations. Soon, massive, highly customized single-product systems will replaced with simple, modular systems that can be turned on or off in response to demand for a plant’s numerous products. With longer-lasting treatments and the move toward boutique lots and personalized medicine, ease of changeover from one product to another will be critical to a manufacturer’s success and competitiveness.

Principal requirements of BioPhorum’s small flexible filler URS

Modular plug-and-play capability is a key concept. Likewise the capability to handle multiple platforms — vials, syringes, or cartridges — is also important. Modularity enables flexibility in terms of capacity expansion or contraction for a particular product, enabling a manufacturer to respond rapidly to patient needs, large or small. Modularity also enables continuous improvement, unlike the one-of-a-kind systems in use today; one modular unit could be used temporarily for testing without halting production entirely.

Other key requirements include:

  • A gloveless isolator, which improves sterility assurance level
  • A low reject rate of <0.05 percent
  • 30 minute changeover time between last good filled unit to first good filled unit
    • 30 minute changeover time between last good filled unit to first good filled unit
    • Standardized, ready-to-use components
    • No human intervention needed inside sterile area after decontamination

How the URS will benefit the industry

This URS establishes an industry benchmark for flexible filling needs and serve to streamline the acquisition and approval of new equipment by both pharma company leadership and regulatory bodies. This will help the industry to move forward in terms of sterility assurance levels, turnaround times, reject rates, and disposable technology.

It will “enable the industry to bring products to patients faster and reduced costs through use of standard components and processes. Standard components and processes mean less customization, reducing the cost of the equipment and the associated cost of qualification. Ultimately, this enables organizations to develop small-batch capabilities in preparation for the future of personalized medicines. In so doing, cost and time-to-market for new treatments will be reduced, ultimately leading to more available and more affordable treatments for patients

The URS lays the foundations of the industries expectations to the equipment supplier. It allows the suppliers to develop the appropriate technology and to focus on the areas that are important to the industry. The URS should also help the vendors understand where future technology innovations needs the industry is having as part of a vision of the future manufacturing state.”

Next steps

The BioPhorum team plans to continue collaborating on establishing alignment and innovation across the industry and with vendors on other unit operations. The biopharmaceutical industry is a highly immature one compared to the automotive, semiconductor, and other sectors. We owe it to patients to continue to improve operations, reduce costs, and increase output of safe and effective treatments for unmet medical needs.

Digital Blue Tick
NEWS
Drive your project faster with the URS of the future

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products support the quest for better and faster development of cell, gene and RNA therapies​ through connecting therapy developers, contract manufacturing, and testing organizations to gain an understanding and respond to the challenges faced by the advanced therapeutics industry.

Development Group

Development Group accelerates and improves the development process of biopharmaceutical medicines for the benefit of the patient. Replacing isolation with collaboration by providing a “safe” space where subject matter experts can work on sharing solutions and best practice on emerging industry trends, implementation of new technologies and common issues whilst ensuring their intellectual property and confidentiality is protected.

Drug Substance

Drug Substance advances excellence in drug substance manufacturing and testing, acting as an industry voice to accelerate technology adoption, implement post-approval change more rapidly and increase confidence in maintaining compliance.

Fill Finish

Fill Finish accelerates development and acceptance of sustainable world-class filling and packaging operations for drug product which meets the future needs of patients. Through innovative solutions resulting from the sharing of expertise, we can overcome common performance challenges and deliver on quality and regulatory compliance.

Information Technology

Information Technology accelerates digital maturity across the ​global pharmaceutical manufacturing industry.

Quality

BioPhorum Quality provides a dedicated, safe space for quality professionals from biomanufacturers and contract organizations to coalesce and enhance effective collaboration to address shared industry challenges.

Regulatory-CMC

Regulatory CMC brings leaders together who have a common goal – to improve access to medicines through innovation in the Regulatory ecosystem. It provides a dedicated space for strategic leadership and a coordinated industry voice, to move from divergence to convergence.

Supply Chain to Patient

Supply Chain to Patient transforms the performance of global pharmaceutical clinical and commercial outbound supply chains through industry collaboration by creating transparent patient-centric, resilient and agile E2E supply chains, that consistently deliver high-quality medicines ensuring an uninterrupted supply to patients.

Supply Partner

Supply Partner is a trusted advisory group and collaboration that is the engine for driving change across the global industry for all things relevant to the inbound supply chain. Addressing the challenges of complexity, resilience, cost, sustainability, and innovation.

Sustainability

Sustainability enables the industry’s transition to a low carbon, circular future – supporting members to improve patient health while respecting the planet. We activate multi-disciplinary teams drawn from our network to deliver environmental sustainability improvements across the value chain.

Technology Strategy

Technology Strategy acts as one voice of the industry to define strategy, accelerate technology transformation and support technology translation and adoption. With a purpose of enabling the future state of flexible, resilient, sustainable end-to-end biomanufacturing.

DOWNLOAD
An industry perspective on understanding AAV capsid content variants
Needle On Yellow Background
EXTERNAL-RESOURCE
An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations
DOWNLOAD
The Drug Substance 2.0 Strategic Value Framework
Coloured dots on teal, next to vial
DOWNLOAD
BioPhorum’s holistic approach to container closure integrity
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
NEWS
Inaugural BioPhorum Quality face to face – get involved
PODCAST
The next step in building regulatory as a capability to enable strategic innovation across the BioPhorum community
PODCAST
Delivering a Cell and Gene Therapy Outbound Supply Chain Pathway for the Industry
DNA and Earth on blue background
DOWNLOAD
A vision for the biopharmaceutical industry’s inbound supply chain
NEWS
A major milestone – a harmonized approach to product carbon footprint data
Technology Roadmap V 2.0
DOWNLOAD
BioPhorum Technology Roadmapping roadmap vision 2.0

Publications

Documents including best practices, vision statements and peer reviewed papers to help you take value back to your business.

Webinars

Discussing all aspects of the biopharmaceutical industry, from digitization and knowledge management to raw materials, supply chain, sustainability and more. Learn from the perspectives of those at the forefront of the industry.

Podcasts

BioPhorum Connect is our podcast series that keeps you up to date with the latest news and trends in the biopharmaceutical industry. From experienced professionals to thought leaders, these podcasts bring you the insights and perspectives of experts from around the world.

Tools

A variety of resources including design tools and user requirement specifications to help you improve and streamline your business processes.

Benchmarks and Surveys

Research conducted among the BioPhorum membership providing evidence to support change and identify best practice.

Browse all

Access a variety of free tools and papers and other resources designed to provide you with up-to-date information and insights to help you make informed decisions and maximize your success. Access our resources today and start making improving and streamlining your business processes.

WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
WEBINAR
Bioreactivity testing in single-use system biomanufacturing